The increase in cancer drug prices is harming our patients and our health care system

  • Americans paid twice as much as Canadians for health care, but they didn’t get twice the benefit, according to a new study of patients with advanced colorectal cancer who lived, in some cases, mere miles from each other.
  • The increase in cancer drug prices in the last 15 years has many contributing factors and is harming our patients and our health care system.
  • With typical out-of-pocket expenses of 20% to 30%, the financial burden of cancer treatment would be $20,000 to 30,000 a year, nearly half of the average annual household income in the United States. Many patients (estimated 10% to 20%) may decide not to take the treatment or may compromise significantly on the treatment plan. Source: Journal of Oncology Practice

Continue reading